Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy - Weller, Michael; Kaulich, Kerstin; Hentschel, Bettina; Felsberg, Joerg; Gramatzki, Dorothee; Pietsch, Torsten; Simon, Matthias; Westphal, Manfred; Schackert, Gabriele; Tonn, Joerg C.; Deimling, Andreas von; Davis, Thomas; et al. (International journal of cancer, 2014)
Gesehen am 19.08.2020